G521R (p.Gly521Arg) variant of PANK2 (Q9BZ23)
G521R (p.Gly521Arg) in PANK2 (Q9BZ23) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of PANK2-related disorder; Inborn genetic diseases; Hypoprebetalipoproteinemia, aca. The available variant effect predictions contribute to a CATVariant prioritization score of 0.94 / 1. The record also includes population frequency data and published literature.
G521R (p.Gly521Arg) variant details
- p.Gly521Arg
- rs137852959
- ClinGen CA116915
- ClinVar RCV000004807
- ClinVar RCV000132732
- Pathogenic/Likely pathogenic
- PANK2-related disorder; Inborn genetic diseases; Hypoprebetalipoproteinemia, aca
- Missense
- Variant Prioritization Score for Impact Estimate 0.939
- ESM-1b 1.00
- AlphaMissense 1.00
- MetaLR 1.00
- MetaSVM 0.91
- CADD 33.00
- PolyPhen-2 1.00
- ClinVar: Pathogenic/Likely pathogenic (PANK2-related disorder; Inborn genetic diseases; Hypoprebetalipo)
- EBI: Pathogenic (in NBIA1)
- UniProt: Pathogenic (in NBIA1)
- Population evidence available
- Cited in: A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. (PMID 11479594)
- Cited in: Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by… (PMID 15659606)